RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
RARX
Delisted
RARX was delisted on the 1st of April, 2020.
62 hedge funds and large institutions have $233M invested in Ra Pharmaceuticals, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 19 increasing their positions, 23 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
62
Holders Change
-14
Holders Change %
-18.42%
% of All Funds
1.42%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
7
Increased
19
Reduced
23
Closed
21
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
First Manhattan
New York
|
$7.74M |
| 2 |
BlackRock
New York
|
$15.3M |
| 3 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
$7.46M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
$807K |
| 5 |
Goldman Sachs
New York
|
$1.33M |
